Our COVID-19 Research
In collaboration with Cochrane France; commissioned by WHO Health Emergencies Programme (WHE); Cochrane Response is part of the operating team of the COVID-19 living systematic review and network meta-analysis initiatiative. COVID-NMA is an international initiative working in conjunction with the World Health Organization (WHO), led by a team of researchers from Cochrane and other institutions (Université de Paris, Inserm, CNRS, Centre for Evidence-Based Medicine Odense (CEBMO), University of Southern Denmark, Odense University Hospital, Epistemonkos Foundation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan). The COVID-NMA initiative has three overarching parts: Latest publications: Davidson M, Menon S, Chaimani A, Evrenoglou T, Ghosn L, Graña C, Henschke N, Cogo E, Villanueva G, Ferrand G, Riveros C, Bonnet H, Kapp P, Moran C, Devane D, Meerpohl JJ, Rada G, Hróbjartsson A, Grasselli G, Tovey D, Ravaud P, Boutron I. Interleukin‐1 blocking agents for treating COVID‐19. Cochrane Database of Systematic Reviews 2022 Ghosn L, Chaimani A, Evrenoglou T, Davidson M, Graña C, Schmucker C, Bollig C, Henschke N, Sguassero Y, Nejstgaard CH, Menon S, Nguyen TV, Ferrand G, Kapp P, Riveros C, Ávila C, Devane D, Meerpohl JJ, Rada G, Hróbjartsson A, Grasselli G, Tovey D, Ravaud P, Boutron I. Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review. Cochrane Database of Systematic Reviews 2021 | |
Rapid reviews on treatments for COVID-19: HydroxychloroquineRapid reviews on treatments for COVID-19: Lopinavir/ritonavir | In collaboration with Cochrane France; commissioned by WHO Health Emergencies Programme (WHE); We deliviered evidence summaries for these rapid reviews to the comissioner |
Changing physical environments to change behaviours to reduce transmission of SARS-CoV-2 | Commissioned by the UK Innovation and Research, Economic and Social Research Council; Scoping review and rapid review: Encouraging behaviour change to reduce COVID-19 transmission: A summary of two rapid evidence reviews |
COVID-19 DTA rapid reviews | Contributing towards updates of the following Cochrane rapid reviews: |